MBOT

Microbot Medical Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 5/10
  • Value↑ 5/10
Microbot Medical sales and earnings growth
MBOT Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 60.00%
  • FCF Y/Y↓ -65.29%
Microbot Medical gross and profit margin trends
MBOT Profitability
Neutral
  • Gross margin ↓ 1.90%
  • EPS margin↓ -13535.20%
  • ROIC 5Y↓ -189.13%
Microbot Medical net debt vs free cash flow
MBOT Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Microbot Medical stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Medical Instruments & Supplies stocks